Literature DB >> 29904935

Physical activity and the risk of colorectal cancer in Lynch syndrome.

S Ghazaleh Dashti1, Aung Ko Win1,2, Sheetal S Hardikar3,4, Stephen E Glombicki5, Sheila Mallenahalli5, Selvi Thirumurthi5, Susan K Peterson6, Y Nancy You7, Daniel D Buchanan1,2,8,9, Jane C Figueiredo10,11, Peter T Campbell12, Steven Gallinger13, Polly A Newcomb3,14, John D Potter3, Noralane M Lindor15, Loic Le Marchand16, Robert W Haile17, John L Hopper1, Mark A Jenkins1, Karen M Basen-Engquist6, Patrick M Lynch5, Mala Pande5.   

Abstract

Greater physical activity is associated with a decrease in risk of colorectal cancer for the general population; however, little is known about its relationship with colorectal cancer risk in people with Lynch syndrome, carriers of inherited pathogenic mutations in genes affecting DNA mismatch repair (MMR). We studied a cohort of 2,042 MMR gene mutations carriers (n = 807, diagnosed with colorectal cancer), from the Colon Cancer Family Registry. Self-reported physical activity in three age-periods (20-29, 30-49 and ≥50 years) was summarized as average metabolic equivalent of task hours per week (MET-hr/week) during the age-period of cancer diagnosis or censoring (near-term exposure) and across all age-periods preceding cancer diagnosis or censoring (long-term exposure). Weighted Cox regression was used to estimate the hazard ratio (HR) and 95% confidence intervals (CI) for the association between physical activity and colorectal cancer risk. Near-term physical activity was associated with a small reduction in the risk of colorectal cancer (HR ≥35 vs. <3.5 MET-hr/week, 0.71; 95% CI, 0.53-0.96). The strength and direction of associations were similar for long-term physical activity, although the associations were not nominally significant. Our results suggest that physical activity is inversely associated with the risk of colorectal cancer for people with Lynch syndrome; however, further confirmation is warranted. The potential modifying effect of physical activity on colorectal cancer risk in people with Lynch syndrome could be useful for risk prediction and support counseling advice for lifestyle modification to reduce cancer risk.
© 2018 UICC.

Entities:  

Keywords:  Lynch syndrome; colorectal cancer; mismatch repair; physical activity

Mesh:

Substances:

Year:  2018        PMID: 29904935      PMCID: PMC6195467          DOI: 10.1002/ijc.31611

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.316


  39 in total

1.  The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer.

Authors:  W S Samowitz; K Curtin; H H Lin; M A Robertson; D Schaffer; M Nichols; K Gruenthal; M F Leppert; M L Slattery
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

Review 2.  Physical activity and cancer prevention: etiologic evidence and biological mechanisms.

Authors:  Christine M Friedenreich; Marla R Orenstein
Journal:  J Nutr       Date:  2002-11       Impact factor: 4.798

3.  A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes.

Authors:  Antonis C Antoniou; David E Goldgar; Nadine Andrieu; Jenny Chang-Claude; Richard Brohet; Matti A Rookus; Douglas F Easton
Journal:  Genet Epidemiol       Date:  2005-07       Impact factor: 2.135

4.  Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.

Authors:  Marietta E Kovacs; Janos Papp; Zoltan Szentirmay; Szabolcs Otto; Edith Olah
Journal:  Hum Mutat       Date:  2009-02       Impact factor: 4.878

5.  Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.

Authors:  Polly A Newcomb; John Baron; Michelle Cotterchio; Steve Gallinger; John Grove; Robert Haile; David Hall; John L Hopper; Jeremy Jass; Loïc Le Marchand; Paul Limburg; Noralane Lindor; John D Potter; Allyson S Templeton; Steve Thibodeau; Daniela Seminara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11-02       Impact factor: 4.254

6.  Cancer risks for MLH1 and MSH2 mutation carriers.

Authors:  James G Dowty; Aung K Win; Daniel D Buchanan; Noralane M Lindor; Finlay A Macrae; Mark Clendenning; Yoland C Antill; Stephen N Thibodeau; Graham Casey; Steve Gallinger; Loic Le Marchand; Polly A Newcomb; Robert W Haile; Graeme P Young; Paul A James; Graham G Giles; Shanaka R Gunawardena; Barbara A Leggett; Michael Gattas; Alex Boussioutas; Dennis J Ahnen; John A Baron; Susan Parry; Jack Goldblatt; Joanne P Young; John L Hopper; Mark A Jenkins
Journal:  Hum Mutat       Date:  2013-03       Impact factor: 4.878

7.  Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.

Authors:  Seyedeh Ghazaleh Dashti; Rowena Chau; Driss Ait Ouakrim; Daniel D Buchanan; Mark Clendenning; Joanne P Young; Ingrid M Winship; Julie Arnold; Dennis J Ahnen; Robert W Haile; Graham Casey; Steven Gallinger; Stephen N Thibodeau; Noralane M Lindor; Loïc Le Marchand; Polly A Newcomb; John D Potter; John A Baron; John L Hopper; Mark A Jenkins; Aung Ko Win
Journal:  JAMA       Date:  2015-07-07       Impact factor: 56.272

8.  Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer.

Authors:  Brenda Diergaarde; Hanneke Braam; Hans F Vasen; Fokko M Nagengast; Goos N P van Muijen; Frans J Kok; Ellen Kampman
Journal:  Clin Gastroenterol Hepatol       Date:  2007-06       Impact factor: 11.382

9.  Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers.

Authors:  S Ghazaleh Dashti; Daniel D Buchanan; Harindra Jayasekara; Driss Ait Ouakrim; Mark Clendenning; Christophe Rosty; Ingrid M Winship; Finlay A Macrae; Graham G Giles; Susan Parry; Graham Casey; Robert W Haile; Steven Gallinger; Loïc Le Marchand; Stephen N Thibodeau; Noralane M Lindor; Polly A Newcomb; John D Potter; John A Baron; John L Hopper; Mark A Jenkins; Aung Ko Win
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-11-03       Impact factor: 4.090

10.  Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.

Authors:  Jessica Ezzell Hunter; Jamilyn M Zepp; Mari J Gilmore; James V Davis; Elizabeth J Esterberg; Kristin R Muessig; Susan K Peterson; Sapna Syngal; Louise S Acheson; Georgia L Wiesner; Jacob A Reiss; Katrina A B Goddard
Journal:  Cancer       Date:  2015-06-02       Impact factor: 6.860

View more
  8 in total

1.  Energy balance related lifestyle factors and risk of endometrial and colorectal cancer among individuals with lynch syndrome: a systematic review.

Authors:  Adriana M Coletta; Susan K Peterson; Leticia A Gatus; Kate J Krause; Susan M Schembre; Susan C Gilchrist; Mala Pande; Eduardo Vilar; Y Nancy You; Miguel A Rodriguez-Bigas; Larkin L Strong; Patrick M Lynch; Karen H Lu; Karen Basen-Engquist
Journal:  Fam Cancer       Date:  2019-06-24       Impact factor: 2.375

2.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer.

Authors:  Naohiro Tomita; Hideyuki Ishida; Kohji Tanakaya; Tatsuro Yamaguchi; Kensuke Kumamoto; Toshiaki Tanaka; Takao Hinoi; Yasuyuki Miyakura; Hirotoshi Hasegawa; Tetsuji Takayama; Hideki Ishikawa; Takeshi Nakajima; Akiko Chino; Hideki Shimodaira; Akira Hirasawa; Yoshiko Nakayama; Shigeki Sekine; Kazuo Tamura; Kiwamu Akagi; Yuko Kawasaki; Hirotoshi Kobayashi; Masami Arai; Michio Itabashi; Yojiro Hashiguchi; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2021-06-29       Impact factor: 3.402

3.  Variation in cancer risk among families with genetic susceptibility.

Authors:  Theodore Huang; Danielle Braun; Henry T Lynch; Giovanni Parmigiani
Journal:  Genet Epidemiol       Date:  2020-10-08       Impact factor: 2.135

4.  Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome.

Authors:  S Ghazaleh Dashti; Wing Yan Li; Daniel D Buchanan; Mark Clendenning; Christophe Rosty; Ingrid M Winship; Finlay A Macrae; Graham G Giles; Sheetal Hardikar; Xinwei Hua; Stephen N Thibodeau; Jane C Figueiredo; Graham Casey; Robert W Haile; Steven Gallinger; Loïc Le Marchand; Polly A Newcomb; John D Potter; Noralane M Lindor; John L Hopper; Mark A Jenkins; Aung Ko Win
Journal:  Br J Cancer       Date:  2019-09-25       Impact factor: 7.640

5.  Body Weight, Physical Activity, and Risk of Cancer in Lynch Syndrome.

Authors:  Tero Sievänen; Timo Törmäkangas; Eija K Laakkonen; Jukka-Pekka Mecklin; Kirsi Pylvänäinen; Toni T Seppälä; Päivi Peltomäki; Sarianna Sipilä; Elina Sillanpää
Journal:  Cancers (Basel)       Date:  2021-04-13       Impact factor: 6.639

Review 6.  Lynch Syndrome: From Carcinogenesis to Prevention Interventions.

Authors:  Donatella Gambini; Stefano Ferrero; Elisabetta Kuhn
Journal:  Cancers (Basel)       Date:  2022-08-24       Impact factor: 6.575

7.  Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium.

Authors:  Pål Møller; Toni Seppälä; James G Dowty; Saskia Haupt; Mev Dominguez-Valentin; Lone Sunde; Inge Bernstein; Christoph Engel; Stefan Aretz; Maartje Nielsen; Gabriel Capella; Dafydd Gareth Evans; John Burn; Elke Holinski-Feder; Lucio Bertario; Bernardo Bonanni; Annika Lindblom; Zohar Levi; Finlay Macrae; Ingrid Winship; John-Paul Plazzer; Rolf Sijmons; Luigi Laghi; Adriana Della Valle; Karl Heinimann; Elizabeth Half; Francisco Lopez-Koestner; Karin Alvarez-Valenzuela; Rodney J Scott; Lior Katz; Ido Laish; Elez Vainer; Carlos Alberto Vaccaro; Dirce Maria Carraro; Nathan Gluck; Naim Abu-Freha; Aine Stakelum; Rory Kennelly; Des Winter; Benedito Mauro Rossi; Marc Greenblatt; Mabel Bohorquez; Harsh Sheth; Maria Grazia Tibiletti; Leonardo S Lino-Silva; Karoline Horisberger; Carmen Portenkirchner; Ivana Nascimento; Norma Teresa Rossi; Leandro Apolinário da Silva; Huw Thomas; Attila Zaránd; Jukka-Pekka Mecklin; Kirsi Pylvänäinen; Laura Renkonen-Sinisalo; Anna Lepisto; Päivi Peltomäki; Christina Therkildsen; Lars Joachim Lindberg; Ole Thorlacius-Ussing; Magnus von Knebel Doeberitz; Markus Loeffler; Nils Rahner; Verena Steinke-Lange; Wolff Schmiegel; Deepak Vangala; Claudia Perne; Robert Hüneburg; Aída Falcón de Vargas; Andrew Latchford; Anne-Marie Gerdes; Ann-Sofie Backman; Carmen Guillén-Ponce; Carrie Snyder; Charlotte K Lautrup; David Amor; Edenir Palmero; Elena Stoffel; Floor Duijkers; Michael J Hall; Heather Hampel; Heinric Williams; Henrik Okkels; Jan Lubiński; Jeanette Reece; Joanne Ngeow; Jose G Guillem; Julie Arnold; Karin Wadt; Kevin Monahan; Leigha Senter; Lene J Rasmussen; Liselotte P van Hest; Luigi Ricciardiello; Maija R J Kohonen-Corish; Marjolijn J L Ligtenberg; Melissa Southey; Melyssa Aronson; Mohd N Zahary; N Jewel Samadder; Nicola Poplawski; Nicoline Hoogerbrugge; Patrick J Morrison; Paul James; Grant Lee; Rakefet Chen-Shtoyerman; Ravindran Ankathil; Rish Pai; Robyn Ward; Susan Parry; Tadeusz Dębniak; Thomas John; Thomas van Overeem Hansen; Trinidad Caldés; Tatsuro Yamaguchi; Verónica Barca-Tierno; Pilar Garre; Giulia Martina Cavestro; Jürgen Weitz; Silke Redler; Reinhard Büttner; Vincent Heuveline; John L Hopper; Aung Ko Win; Noralane Lindor; Steven Gallinger; Loïc Le Marchand; Polly A Newcomb; Jane Figueiredo; Daniel D Buchanan; Stephen N Thibodeau; Sanne W Ten Broeke; Eivind Hovig; Sigve Nakken; Marta Pineda; Nuria Dueñas; Joan Brunet; Kate Green; Fiona Lalloo; Katie Newton; Emma J Crosbie; Miriam Mints; Douglas Tjandra; Florencia Neffa; Patricia Esperon; Revital Kariv; Guy Rosner; Walter Hernán Pavicic; Pablo Kalfayan; Giovana Tardin Torrezan; Thiago Bassaneze; Claudia Martin; Gabriela Moslein; Aysel Ahadova; Matthias Kloor; Julian R Sampson; Mark A Jenkins
Journal:  Hered Cancer Clin Pract       Date:  2022-10-01       Impact factor: 2.164

8.  Is a colorectal neoplasm diagnosis a trigger to change dietary and other lifestyle habits for persons with Lynch syndrome? A prospective cohort study.

Authors:  Jesca G M Brouwer; Merel Snellen; Tanya M Bisseling; Jan Jacob Koornstra; Hans F A Vasen; Ellen Kampman; Fränzel J B van Duijnhoven
Journal:  Fam Cancer       Date:  2020-08-08       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.